Literature DB >> 25755581

Infections after orthotopic liver transplantation.

Mark Pedersen1, Anil Seetharam1.   

Abstract

Opportunistic infections are a leading cause of morbidity and mortality after orthotopic liver transplantation. Systemic immunosuppression renders the liver recipient susceptible to de novo infection with bacteria, viruses and fungi post-transplantation as well to reactivation of pre-existing, latent disease. Pathogens are also transmissible via the donor organ. The time from transplantation and degree of immunosuppression may guide the differential diagnosis of potential infectious agents. However, typical systemic signs and symptoms of infection are often absent or blunted after transplant and a high index of suspicion is needed. Invasive procedures are often required to procure tissue for culture and guide antimicrobial therapy. Antimicrobial prophylaxis reduces the incidence of opportunistic infections and is routinely employed in the care of patients after liver transplant. In this review, we survey common bacterial, fungal, and viral infections after orthotopic liver transplantation and highlight recent developments in their diagnosis and management.

Entities:  

Keywords:  BAL, bronchoalveolar lavage; CMV, cytomegalovirus; EBV, epstein–Barr virus; ELISA, enzym linked immunosorbent assay; FCN2, ficolin-2; GM, galactomannan; HAT, hepatic artery thrombosis; HBIG, hepatitis B immune globulin; HBV, hepatitis B virus; HCV, hepatitis C virus; HHV, human herpesvirus; LDLT, live donor liver transplantation; MASP2, MBL-associated serine protease; MBL, mannan-binding lectin; MDR, multi-drug resistant; MELD, model for end-stage liver disease; NAS, non-anastomotic stricture; OLT, orthotopic liver transplantation; PPD, purified protein derivative; PTLD, post-transplant lymphoproliferative disorder; SNP, single nucleotide polymorphism; TLR, toll-like receptor; U, unit; cytomegalovirus; donor transmission; infection; liver transplantation; prophylaxis

Year:  2014        PMID: 25755581      PMCID: PMC4298628          DOI: 10.1016/j.jceh.2014.07.004

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  146 in total

Review 1.  Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.

Authors:  Monique A S H Mennink-Kersten; J Peter Donnelly; Paul E Verweij
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

Review 2.  Liver transplant from Anti-HBc-positive, HBsAg-negative donor into HBsAg-negative recipient: is it safe? A systematic review of the literature.

Authors:  Vivian Iida Avelino-Silva; Luiz Augusto Carneiro D'Albuquerque; Patrícia Rodrigues Bonazzi; Alice Tung Wan Song; João Luiz Miraglia; Alan De Brito Neves; Edson Abdala
Journal:  Clin Transplant       Date:  2010 Nov-Dec       Impact factor: 2.863

3.  Risk factors for early bacterial infections in liver transplantation.

Authors:  V Avkan-Oguz; S Ozkardesler; T Unek; M Ozbilgin; M Akan; E Firuzan; H Kose; I Astarcioglu; S Karademir
Journal:  Transplant Proc       Date:  2013-04       Impact factor: 1.066

Review 4.  Risk factors for infection after liver transplantation.

Authors:  Bart van Hoek; Bert-Jan de Rooij; Hein W Verspaget
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-02       Impact factor: 3.043

5.  Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.

Authors:  Manav Wadhawan; Subash Gupta; Neerav Goyal; Karisangal R Vasudevan; Kausar Makki; Reetika Dawar; Raman Sardana; Nand Lal; Ajay Kumar
Journal:  Liver Transpl       Date:  2012-12       Impact factor: 5.799

Review 6.  Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data.

Authors:  Jon-Erik C Holty; Michael K Gould; Laura Meinke; Emmet B Keeffe; Stephen J Ruoss
Journal:  Liver Transpl       Date:  2009-08       Impact factor: 5.799

7.  Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.

Authors:  José María Aguado; Julián Torre-Cisneros; Jesús Fortún; Natividad Benito; Yolanda Meije; Antonio Doblas; Patricia Muñoz
Journal:  Clin Infect Dis       Date:  2009-05-01       Impact factor: 9.079

8.  Disseminated tuberculosis following liver transplant presenting with an axillary abscess.

Authors:  Emma Ladds
Journal:  BMJ Case Rep       Date:  2014-02-07

9.  Tuberculosis in solid-organ transplant recipients: disease characteristics and outcomes in the current era.

Authors:  Hsin-Yun Sun; Patricia Munoz; Julian Torre-Cisneros; Jose M Aguado; Roberta Lattes; Miguel Montejo; Ana Garcia-Reyne; Emilio Bouza; Maricela Valerio; Rosario Lara; Marilyn M Wagener; George T John; Didier Bruno; Nina Singh
Journal:  Prog Transplant       Date:  2014-03       Impact factor: 1.187

10.  QuantiFERON-TB Gold In-Tube test for diagnosis of latent tuberculosis (TB) infection in solid organ transplant candidates: a single-center study in an area endemic for TB.

Authors:  Z Ahmadinejad; F Azmoudeh Ardalan; M Razzaqi; S Davoudi; A Jafarian
Journal:  Transpl Infect Dis       Date:  2012-11-23       Impact factor: 2.228

View more
  11 in total

1.  Hepatobiliary quiz (answers)-13 (2015).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2015-03-21

Review 2.  [Spectrum of pathogens in postoperative complications of visceral surgery : The problem of multidrug resistance].

Authors:  A Kramer; J Pochhammer; P Walger; U Seifert; M Ruhnke; J C Harnoss
Journal:  Chirurg       Date:  2017-05       Impact factor: 0.955

3.  Machine-Learning Algorithms Predict Graft Failure After Liver Transplantation.

Authors:  Lawrence Lau; Yamuna Kankanige; Benjamin Rubinstein; Robert Jones; Christopher Christophi; Vijayaragavan Muralidharan; James Bailey
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

4.  Risk factors for early viral infections after liver transplantation.

Authors:  Cornelius Johannes Busch; Benedikt Hermann Siegler; Heike Werle; Christoph Lichtenstern; Thomas Bruckner; Alexandra Heininger; Arianeb Mehrabi; Karl Heinz Weiss; Markus Alexander Weigand; Marcel Hochreiter
Journal:  Langenbecks Arch Surg       Date:  2018-04-25       Impact factor: 3.445

Review 5.  Iron: an essential nutrient for Aspergillus fumigatus and a fulcrum for pathogenesis.

Authors:  Efthymia I Matthaiou; Gabriele Sass; David A Stevens; Joe L Hsu
Journal:  Curr Opin Infect Dis       Date:  2018-12       Impact factor: 4.915

6.  Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study.

Authors:  Mercedes Martinez; Emily R Perito; Pamela Valentino; Cara L Mack; Madeleine Aumar; Annemarie Broderick; Laura G Draijer; Eleonora D T Fagundes; Katryn N Furuya; Nitika Gupta; Simon Horslen; Maureen M Jonas; Binita M Kamath; Nanda Kerkar; Kyung Mo Kim; Kaija-Leena Kolho; Bart G P Koot; Trevor J Laborda; Christine K Lee; Kathleen M Loomes; Tamir Miloh; Douglas Mogul; Saeed Mohammed; Nadia Ovchinsky; Girish Rao; Amanda Ricciuto; Alexandre Rodrigues Ferreira; Kathleen B Schwarz; Vratislav Smolka; Atsushi Tanaka; Mary E M Tessier; Venna L Venkat; Bernadette E Vitola; Marek Woynarowski; Melissa Zerofsky; Mark R Deneau
Journal:  Hepatology       Date:  2021-09-09       Impact factor: 17.298

Review 7.  Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment.

Authors:  Jamie C DeWitt; Dori R Germolec; Robert W Luebke; Victor J Johnson
Journal:  Curr Protoc Toxicol       Date:  2016-02-01

Review 8.  Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission.

Authors:  Giulia Freer; Paola Quaranta; Mauro Pistello
Journal:  J Immunol Res       Date:  2016-12-01       Impact factor: 4.818

9.  A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome.

Authors:  Giuseppe Ronzitti; Giulia Bortolussi; Remco van Dijk; Fanny Collaud; Severine Charles; Christian Leborgne; Patrice Vidal; Samia Martin; Bernard Gjata; Marcelo Simon Sola; Laetitia van Wittenberghe; Alban Vignaud; Philippe Veron; Piter J Bosma; Andres F Muro; Federico Mingozzi
Journal:  Mol Ther Methods Clin Dev       Date:  2016-07-20       Impact factor: 6.698

10.  Protective effects of new Wenshen Shengjing Decoction on cyclosporine-induced impairment of testosterone synthesis and spermatogenic apoptosis.

Authors:  Xiaoyan Pan; Xiyan Wang; Xuenan Wang; Wansheng Zhang; Zhanxuan Sun; Xuanxuan Liang; Xue Zhang; Wenjun Li; Zhixin Li
Journal:  Exp Ther Med       Date:  2017-11-08       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.